Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Unicycive Therapeutics Inc (NQ: UNCY )

0.5529 +0.0029 (+0.53%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 347
Open 0.5529
Bid (Size) 0.5700 (1)
Ask (Size) 0.6100 (59)
Prev. Close 0.5500
Today's Range 0.5529 - 0.5529
52wk Range 0.4004 - 1.640
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Unicycive: This Biotech Company Receives Promising Results From New Trial
Unicycive: This Biotech Company Receives Promising Results From New Trial 
Via News Direct

Performance

YTD
+10.56%
+10.56%
1 Month
+22.87%
+22.87%
3 Month
-29.01%
-29.01%
6 Month
-36.43%
-36.43%
1 Year
-58.43%
-58.43%

More News

Read More
Unicycive: This Biotech Company Receives Promising Results From New Trial
Via Benzinga
Unicycive Announces Exclusive License and Development Agreement with Lotus for Renazorb in the Republic of Korea
From Unicycive Therapeutics, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Unicycive Therapeutics' Geographic Atrophy Candidate Shows Improved Contrast Vision In Animal Studies
Via Benzinga
Unicycive Announces Acceptance of Three Abstracts for Presentation at the National Kidney Foundation’s Spring Clinical Meetings
From Unicycive Therapeutics, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Unicycive Announces Acceptance of Four Abstracts for Presentation at the World Congress of Nephrology 2023
From Unicycive Therapeutics, Inc.
Via Globe NewsWire
Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket
Via Benzinga
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Unicycive Announces Termination of “At-The-Market” Offering of Shares of Common Stock
From Unicycive Therapeutics, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Cal-Maine Foods Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket
Via Benzinga
Nasdaq Down 100 Points; Kala Pharmaceuticals Shares Spike Higher
Via Benzinga
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Tumbles 150 Points; Crude Oil Falls Sharply
Via Benzinga
Unicycive Shares Jump As Renazorb Achieves Primary Endpoint In Bioequivalence Study
Via Benzinga
Unicycive Achieves Primary Endpoint in Pivotal Bioequivalence Study of Renazorb
From Unicycive Therapeutics, Inc.
Via Globe NewsWire
Unicycive Issued Notice of Acceptance to Initiate Phase 1 Study of UNI-494 Following Review of Clinical Trial Application by the Medicines and Healthcare Products Regulatory Agency in the United Kingdom
From Unicycive Therapeutics, Inc.
Via Globe NewsWire
Unicycive Therapeutics, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
Via ACCESSWIRE
Planned Government Move To Expand Access To Drugs For End-Stage Renal Disease Patients Could Shine The Spotlight On Unicycive
Via Benzinga
Unicycive to Participate in Upcoming Investor Conferences
From Unicycive Therapeutics, Inc.
Via Globe NewsWire
Unicycive Reports Key Findings of UNI-494 Efficacy in Preclinical Animal Model of Geographic Atrophy
From Unicycive Therapeutics, Inc.
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.